Citation Impact

Citing Papers

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Adipocytes Impair Leukemia Treatment in Mice
2009
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
2006
Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas
2005
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction ofbcl-2 Gene Expression
1994
Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia.
1993
The Bcl-2 family of proteins: regulators of cell death and survival
1994
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
2004
Molecular mechanisms of drug resistance
2005
Cancer drug resistance: an evolving paradigm
2013 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
2006
X-linked IAP is a direct inhibitor of cell-death proteases
1997 StandoutNature
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
1996 Standout
The Bcl2 family: regulators of the cellular life-or-death switch
2002 Standout
HSP90 and the chaperoning of cancer
2005 Standout
Bcl-2 Family Proteins: Strategies for Overcoming Chemoresistance in Cancer
1997
The biochemistry of apoptosis
2000 StandoutNature
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
1997 Standout
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
The versatility and universality of calcium signalling
2000 Standout
Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model
1999
Death receptors in chemotherapy and cancer
2004
The proto-oncogene Bcl-2 and its role in regulating apoptosis
1997 Standout
Biology and management of relapsed acute myeloid leukaemia
2005
Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells
2000
Malignant Gliomas in Adults
2008 Standout
Structure-Function Analysis of Bcl-2 Protein
1995
Apoptosis
2002 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Molecular signals in anti-apoptotic survival pathways
2001
Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers
2002
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells
2005
Dysregulation of apoptosis genes in hematopoietic malignancies
2002
Autophagy in cell death: an innocent convict?
2005 Standout
The C. elegans Cell Death Specification Gene ces-1 Encodes a Snail Family Zinc Finger Protein
1999 StandoutNobel
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Escaping Cell Death: Survival Proteins in Cancer
1999
Programmed Cell Death in Animal Development
1997 Standout
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
1997
The BCL-2 protein family: opposing activities that mediate cell death
2007 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Apoptosis in the Failing Human Heart
1997 Standout
A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment
2007
Direct Interaction of the Mitochondrial Membrane Protein Carnitine Palmitoyltransferase I with Bcl-2
1997 StandoutNobel
Heat shock proteins – modulators of apoptosis in tumour cells
2000
Defects in the Ubiquitin Pathway Induce Caspase-independent Apoptosis Blocked by Bcl-2
1998 StandoutNobel
Biochemical Modulation of Cisplatin Mechanisms of Action:  Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage
1996
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Human Immunodeficiency Virus Induces a Dual Regulation of Bcl-2, Resulting in Persistent Infection of CD4+T- or Monocytic Cell Lines
1998 StandoutNobel
Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline
1999 StandoutNobel
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Antitumor Antibiotics:  Bleomycin, Enediynes, and Mitomycin
2005 Standout
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Randomized Phase II Study of Fludarabine + Cytosine Arabinoside + Idarubicin ± All-Trans Retinoic Acid ± Granulocyte Colony-Stimulating Factor in Poor Prognosis Newly Diagnosed Acute Myeloid Leukemia and Myelodysplastic Syndrome
1999
Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.
1995
Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse
1998
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
Randomized Phase II Study of Fludarabine + Cytosine Arabinoside + Idarubicin ± All-Trans Retinoic Acid ± Granulocyte Colony-Stimulating Factor in Poor Prognosis Newly Diagnosed Acute Myeloid Leukemia and Myelodysplastic Syndrome
1999
APOPTOSIS AND DISEASE: Regulation and Clinical Relevance of Programmed Cell Death
1997
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma
1997
Bcl-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor α Chimeric Protein (Pmlrarα) to Block Neutrophil Differentiation and Initiate Acute Leukemia
2001 Nobel
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
1997 StandoutScience
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2
1994
(−)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance
2005
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
1999 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma
1997
Solution structure of the antiapoptotic protein bcl-2
2001
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin
2004
Expression and Regulation of Bcl-2, Bcl-xl, and Bax Correlate With p53 Status and Sensitivity to Apoptosis in Childhood Acute Lymphoblastic Leukemia
1997
Cellular stress response and apoptosis in cancer therapy
2001
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
1999 StandoutScience
Prognostic Significance of Bax Protein Expression in Diffuse Aggressive Non-Hodgkin's Lymphoma
1997
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
BCL2 translocations in leukemias of mature B cells
1994
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
1996
Cryptococcus neoformansCapsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages
2005
Disruption of epithelial cell-matrix interactions induces apoptosis
1994 Standout
Bcl-2 and the regulation of programmed cell death
1994 Standout

Works of C. Vasselon being referenced

t(2; 18) and t(18;22) Variant Chromosomal Translocations in B Cell Malignancies
1992
Expression of Apoptosis-Controlling Proteins in Acute Leukemia Cells
1999
Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes
2002
Retro-Orbital Chloroma in Children with t(8;21) Acute Myeloblastic Leukemia of M2 Type Two New Cases and Literature Review
1988
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
1993
Chromosome studies in stimulated lymphocytes of 50 patients with B-cell chronic lymphocytic leukemia.
1992
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
1993
Rankless by CCL
2026